Observation of Patients With Metastatic Colorectal Cancer Starting Chemotherapy Combined With Bevacizumab (Avastin)
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This is a longitudinal, multicenter, prospective, pharmacoepidemiological study to evaluate
progression free survival (PFS) in a real-life setting in participants with metastatic
colorectal cancer (mCRC) starting chemotherapy combined with bevacizumab.